Ordinary Index Rebalancing in the North American Psychedelics Index | June 2021
In the ordinary rebalance the following composition will be implemented over a period starting on 17.06.2021 (cob) and ending on 18.06.2021 (cob) . The new composition and target weights will be fully reflected in the index open 21.06.2021:
| JOHNSON & JOHNSON |
| ABBVIE INC |
| MYDECINE INNOVATIONS GROUP INC |
| ALGERNON PHARMACEUTICALS INC |
| CORE ONE LABS INC |
| SEELOS THERAPEUTICS INC |
| BETTERLIFE PHARMA INC |
| LOBE SCIENCES LTD |
| REVIVE THERAPEUTICS LTD |
| MIND MEDICINE MINDMED INC |
| RED LIGHT HOLLAND CORP |
| Compass Pathways PLC |
| FIELD TRIP HEALTH LTD |
| MIND CURE HEALTH INC |
| NUMINESS WELLNESS INC |
| HAVN LIFE SCIENCES INC |
| GREENBROOK TMS INC |
| PSYCHED WELLNESS LTD |
| ENTHEON BIOMEDICAL CORP |
| CYBIN INC |
| MINDSET PHARMA INC |
| NOVAMIND INC |
| OPTIMI HEALTH CORP |